Kimberly A. Maguschak, Ph.D. - Publications

Affiliations: 
2010 Emory University, Atlanta, GA 
Area:
Fear conditioning

8/12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Maguschak KA, Ressler KJ. A role for WNT/β-catenin signaling in the neural mechanisms of behavior. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 763-73. PMID 22415718 DOI: 10.1007/S11481-012-9350-7  0.45
2012 Maguschak KA, Ressler KJ. The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology. 62: 78-88. PMID 21903109 DOI: 10.1016/J.Neuropharm.2011.08.032  0.526
2011 Maguschak KA, Ressler KJ. Wnt signaling in amygdala-dependent learning and memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13057-67. PMID 21917789 DOI: 10.1523/JNEUROSCI.3248-11.2011  0.51
2010 Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ. Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proceedings of the National Academy of Sciences of the United States of America. 107: 2675-80. PMID 20133801 DOI: 10.1073/Pnas.0909359107  0.605
2009 Jasnow AM, Rainnie DG, Maguschak KA, Chhatwal JP, Ressler KJ. Construction of cell-type specific promoter lentiviruses for optically guiding electrophysiological recordings and for targeted gene delivery. Methods in Molecular Biology (Clifton, N.J.). 515: 199-213. PMID 19378132 DOI: 10.1007/978-1-59745-559-6_13  0.529
2009 Chhatwal JP, Gutman AR, Maguschak KA, Bowser ME, Yang Y, Davis M, Ressler KJ. Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 509-21. PMID 18580872 DOI: 10.1038/Npp.2008.97  0.59
2008 Maguschak KA, Ressler KJ. Beta-catenin is required for memory consolidation. Nature Neuroscience. 11: 1319-26. PMID 18820693 DOI: 10.1038/nn.2198  0.449
2005 Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 516-24. PMID 15637635 DOI: 10.1038/Sj.Npp.1300655  0.601
Low-probability matches (unlikely to be authored by this person)
2002 Carmody RJ, Hilliard B, Maguschak K, Chodosh LA, Chen YH. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. Journal of Neuroimmunology. 133: 95-107. PMID 12446012 DOI: 10.1016/S0165-5728(02)00366-1  0.175
2003 Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nature Immunology. 4: 255-60. PMID 12577054 DOI: 10.1038/Ni894  0.127
2001 Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Research. 888: 51-59. PMID 11146051 DOI: 10.1016/S0006-8993(00)03004-3  0.12
2006 Carmody RJ, Maguschak K, Chen YH. A novel mechanism of nuclear factor-kappaB regulation by adenoviral protein 14.7K. Immunology. 117: 188-95. PMID 16423054 DOI: 10.1111/J.1365-2567.2005.02277.X  0.096
Hide low-probability matches.